Literature DB >> 12093905

Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure.

D Gregg Rokosh1, Paul C Simpson.   

Abstract

alpha 1-adrenergic receptors (ARs) play a major role in blood pressure regulation. The three alpha 1-AR subtypes (A/C, B, and D) stimulate contraction of isolated arteries, but it is uncertain how different subtypes contribute to blood pressure regulation in the intact animal. We studied the role of the alpha 1A/C subtype by using gene knockout. alpha 1A/C knockout (KO) mice were viable and overtly normal. The LacZ reporter gene replaced alpha 1A/C coding sequence in the KO, and beta-galactosidase staining was present in resistance arteries and arterioles, but not in the thoracic aorta or its main branches. By tail cuff manometer and arterial catheter in conscious mice, alpha 1A/C KO mice were hypotensive at rest, with an 8-12% reduction of blood pressure dependent on alpha 1A/C gene copy number. A61603, an alpha 1A/C-selective agonist, caused a pressor response that was lost in the KO and reduced but significant in heterozygous mice with a single copy of the alpha 1A/C. A subtype-nonselective agonist [phenylephrine (PE)] caused a pressor response in KO mice, but the final arterial pressure was only 85% of wild type. The baroreflex was reset in the KO, and heart rate variability was decreased. After baroreflex blockade with atropine, PE increased blood pressure but did not change heart rate. Cardiac and vascular responses to the beta-AR agonist isoproterenol were unchanged, and the arterial lumen area was not altered. We conclude that the alpha 1A/C-AR subtype is a vasopressor expressed in resistance arteries and is required for normal arterial blood pressure regulation. alpha 1A/C-selective antagonists might be desirable antihypertensive agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093905      PMCID: PMC123165          DOI: 10.1073/pnas.132552699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  Do alpha blockers cause heart failure and stroke? Observations from ALLHAT.

Authors:  D G Beevers; G Y Lip
Journal:  J Hum Hypertens       Date:  2000-05       Impact factor: 3.012

2.  Diuretics vs alpha-blockers for treatment of hypertension: lessons from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  L Lasagna
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 3.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 4.  Insights from in vivo modification of adrenergic receptor gene expression.

Authors:  D K Rohrer; B K Kobilka
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

5.  Alterations in dynamic heart rate control in the beta 1-adrenergic receptor knockout mouse.

Authors:  D K Rohrer; E H Schauble; K H Desai; B K Kobilka; D Bernstein
Journal:  Am J Physiol       Date:  1998-04

6.  Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C.

Authors:  D G Rokosh; A F Stewart; K C Chang; B A Bailey; J S Karliner; S A Camacho; C S Long; P C Simpson
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

7.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

8.  A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT).

Authors:  R M Guthrie; R L Siegel
Journal:  Clin Ther       Date:  1999-10       Impact factor: 3.393

9.  Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease.

Authors:  K H Desai; R Sato; E Schauble; G S Barsh; B K Kobilka; D Bernstein
Journal:  Am J Physiol       Date:  1997-02

Review 10.  Alpha-adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates.

Authors:  M T Piascik; E E Soltis; M M Piascik; L B Macmillan
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

View more
  59 in total

1.  The residual nonadrenergic contractile response to nerve stimulation of the mouse prostate is mediated by acetylcholine but not ATP in a comparison with the mouse vas deferens.

Authors:  Carl W White; Jennifer L Short; John M Haynes; Richard J Evans; Sabatino Ventura
Journal:  J Pharmacol Exp Ther       Date:  2010-08-19       Impact factor: 4.030

2.  Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.

Authors:  Chihiro Hosoda; Akito Tanoue; Mari Shibano; Yoshio Tanaka; Masami Hiroyama; Taka-aki Koshimizu; Susanna Cotecchia; Tadaichi Kitamura; Gozoh Tsujimoto; Katsuo Koike
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

3.  Reduced alpha-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock.

Authors:  Shizue Masuki; Takeshi Todo; Yasushi Nakano; Hitoshi Okamura; Hiroshi Nose
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

4.  Prolonged bed rest impairs rapid CPI-17 phosphorylation and contraction in rat mesenteric resistance arteries to cause orthostatic hypotension.

Authors:  Toshio Kitazawa; Kazuyo Kitazawa
Journal:  Pflugers Arch       Date:  2017-07-17       Impact factor: 3.657

5.  Alpha1-adrenoceptors are required for normal male sexual function.

Authors:  A Sanbe; Y Tanaka; Y Fujiwara; H Tsumura; J Yamauchi; S Cotecchia; K Koike; G Tsujimoto; A Tanoue
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

6.  Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors.

Authors:  S Morishima; F Suzuki; H Yoshiki; A S Md Anisuzzaman; Z S Sathi; T Tanaka; I Muramatsu
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

7.  Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice.

Authors:  Carl W White; Yan-Ting Choong; Jennifer L Short; Betty Exintaris; Daniel T Malone; Andrew M Allen; Richard J Evans; Sabatino Ventura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist.

Authors:  Bat-Erdene Myagmar; Taylor Ismaili; Philip M Swigart; Anaha Raghunathan; Anthony J Baker; Sunil Sahdeo; Jonathan M Blevitt; Marcos E Milla; Paul C Simpson
Journal:  Circ Res       Date:  2019-08-20       Impact factor: 17.367

9.  Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload.

Authors:  Timothy D O'Connell; Philip M Swigart; M C Rodrigo; Shinji Ishizaka; Shuji Joho; Lynne Turnbull; Laurence H Tecott; Anthony J Baker; Elyse Foster; William Grossman; Paul C Simpson
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

10.  Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific.

Authors:  Brian C Jensen; Philip M Swigart; Paul C Simpson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.